Recall D-0010-2027

US Class II Ongoing · initiated 2026-09-17

Recalling firm

Ajanta Pharma USA Inc, NJ

Product

Ranolazine Extended-Release Tablets, 1000 mg, 60-count bottle, Rx Only, Marketed by: Ajanta Pharma USA Inc., Bridgewater, NJ 08807. NDC: 27241-126-02

Reason for recall

Failed Dissolution Specifications: below specification

← All recalls